ITA | ENG
  • HOME
  • Company profile
  • Products
  • Production & Warehouses
  • Research & Development
  • Assurance & Quality control
  • Certification & Environmental policy
  • Patents, innovations, technologies
  • Corporate video
  • News
  • Contacts
  • ENG
  • ITA

Patents, innovations, technologies

BREVETTI

PROCEMSA revolutionizes the new way of doing research applied to nutraceuticals, medical devices and cosmetics, using its great knowledge gained in 80 years of experience with the most modern technologies.
Technological platforms, patents that combine technologies, exclusive raw materials born from the collaboration with research institutions, to offer our customers truly innovative products with greater functionality and bioavailability.
Procemsa's research lines are currently focusing on the development of innovative products to support the immune system and in general to improve the quality of life while respecting the environment.

PATENTS
  • PATENT N. IT1395351 composition and method to obtain food emulsions and micellar dispersions by using mono and polyunsaturated fatty acids
  • PATENT N.IT102016000017165 solid, stabilized, rapid release and / or modified therapeutic system for the oral administration of liquid active ingredients
  • PATENT N.PCT WO03 / 039521 LIMOR TECHNOLOGY solid, stabilized, rapid release and / or modified therapeutic system for the oral administration of liquid active ingredients
  • PATENT N.PCT WO03 / 002101 IOR TECHNOLOGY oral pharmaceutical composition with improved bioavailability
  • PATENT N.WO03 / 002151 MOR TECHNOLOGY oral pharmaceutical compositions with modified release of the active ingredient
  • PATENT N. IT379203; EP2197414; US8501203 US8501203 Formulation for topical use for the treatment of cellulite
  • PATENT IT 102017000011632; PATENT PENDING N. PCTIB2018050677 composition based on probiotics in liquid food for babies
  • PATENT IT102017000048750; PATENT PENDING N.PCTIB2018053128 composition for the treatment of mouth ulcers and canker sores

INNOVAZIONI

INNOVATIONS - PROPRIETARY RAW MATERIALS AND TRADEMARKS


ALFAMEL was born in the Procemsa laboratories after careful university studies and is the result of sophisticated extraction techniques on the AlfaAlfa plant (Medicago sativa) that have enriched the phytocomplex with a tripeptide with a cosmetic action on cellulite blemishes, conveyed with the exclusive carrier of melatonin. The functional association of alpha alpha extract and melatonin is protected by 3 international patents and products containing it have been the subject.

Learn more


ROSHIELD is the first extract of Procemsa's new innovation philosophy, obtained with a new extraction technology starting from Rosa damascena flowers and HMW hyaluronic acid, it is used in all our 5 CE class IIa Medical Devices for application on canker sores and stomatitis and in teething gel for children over 6 months of age.

Learn more

TECNOLOGIE

TECHNOLOGIES

603be3640a482


Technology for the development and production of multilayer tablets with optimal distribution of the active ingredients and design of differentiated releases


Technology for obtaining an increased oral release, through the use of specific excipients that allow to improve the absorption of poorly soluble or low oral bioavailability active ingredients


Technology for the development and production of gastro-resistant tablets, with optimal isolation of the active ingredients from the gastric mucosa

603be3640abbc


Technology for obtaining Tabgum, chewable tablets with rapid release of the active ingredients contained


Technology for obtaining instant semi-solid forms of jellies / puddings / creams, through the use of hydrocolloids


Technology for improving the stability of probiotics in different packaging systems

603be3640b339


Technology for the development and production of stable effervescent powders and tablets containing vitamins, minerals, plant extracts


Technology for obtaining oral liquids transformed through a process of transformation of liquid raw materials in a solid or semi-solid state, ensuring greater stability


Technology for the development and production of tablets based on various active ingredients with a pleasant sparkling effect in the mouth

603be3640ba5c


Technology for obtaining hydrophilic or lipophilic oral suspensions using dispersing agents


Flavored film-forming technology of the tablets for the improvement of the organoleptic characteristics, in terms of smell and taste

//www.procemsa.it/wp-content/uploads/2021/02/logo-footer-2021.png



//www.procemsa.it/wp-content/uploads/2021/01/investindustrial-footer.png

Page Copyright

© 2020 All Rights Reserved - Farmaceutici Procemsa S.p.A. - P.I. IT 07410740018 - Capitale Sociale: 3.500.000 i.v. - R.E.A. n. 890209
Powered by Aries Srl

This site does NOT use any cookie profiling. Technical cookies are used by third parties related to improve your browsing experience. I agree Read more
Privacy & Cookies Policy

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary
Always Enabled

Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.

Non-necessary

Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.